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Abstract
Purpose Restless legs syndrome (RLS) is a frequent sensori-
motor disorder characterized by an urge to move the legs, with
symptoms appearing during the night and disturbing nocturnal
sleep. There is a growing body of evidence that RLS correlates
with an increased risk of cardiovascular diseases and hyper-
tension. The aim of this study was to test the hypothesis that
patients with RLS have higher blood pressure (BP) during the
night than people without RLS.
Methods We have analyzed polysomnographic (PSG) record-
ings of 30 patients with RLS and 27 subjects without the sleep
disorder. During PSG, beat-to-beat BP measurement was
performed.
Results Patients with RLS have higher nocturnal and sleep-
time systolic blood pressure compared to controls (124.4 vs.
116.5 mmHg, p < 0.05; 123.5 vs. 116.1 mmHg, p < 0.05).
There was no noticeable dip in the values of nocturnal systolic
pressure of patients with RLS.
Conclusions Our results support the hypothesis that RLS and
hypertension are linked. Thus, we believe patients with RLS
require close observation with regard to cardiovascular risk
factors.
Keywords Restless legs syndrome . Blood pressure .
Hypertension
Introduction
Restless legs syndrome (RLS) is a sensorimotor disorder
with a prevalence in the general population of 5–8.8 %
[1] and is characterized by the presence of an irresist-
ible urge to move the legs frequently accompanied by
unpleasant sensations in the lower limbs. Symptoms ap-
pear at night or during rest and are relieved by satisfy-
ing the urge (i.e., moving the legs [2]). Untreated RLS
may lead to insomnia and fatigue.
As described in an extensive review by Ferini-Strambi et al.
[3], mounting evidence strongly supports the existence of a
link between RLS and cardiovascular diseases (CVD) includ-
ing hypertension. Nevertheless, causality, or even the direc-
tion of possible causality, is still far from established.
Considering the clinical consequences and prevalence of hy-
pertension on one hand, and the high prevalence of RLS on
the other, efforts aimed at clarifying this relationship are easily
justified. Cross-sectional population studies have suggested a
higher prevalence of hypertension in the population of sub-
jects with RLS [4–6], but other authors have not found the
same result [7, 8]. Notably, though, Erden et al. have found
that RLS is an independent determinant for abnormal blood
pressure (BP) patterns in which BP does not dip at night (non-
dipping pattern) [9].
Attempts to explain the relationship between RLS and BP
on the basis of the microarchitecture of sleep have focused on
the role of periodic limb movements in sleep (PLMS). PLMS
are stereotypical, involuntary movements of the lower limbs
during sleep, lasting from 0.5 to 10 s, in series with intervals of
5 to 90 s between single movements [10, 11]. An increased
number of PLMS is found in approximately 80 % of RLS
subjects [12]. Furthermore, PLMS are followed by a signifi-
cant increase in BP, in both patients with RLS and healthy
subjects [13–15]. It is hypothesized that these repetitive
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increases in BP during the night may lead to the development
of more persistent hypertension in patients with RLS.
A possible role of RLS as a risk factor for hypertension or
cardiovascular morbidity was analyzed in large epidemiologic
projects. The impact of PLMS on blood pressure was assessed
in single night polysomnographic studies. RLS and PLMS are
frequently considered as a clinical continuum although they
are not synonymous. Therefore, publications focusing on the
influence of RLS on nocturnal blood pressure are missing.
Based on these data, the aim of this study was to test the
hypothesis that nocturnal blood pressure is higher in patients
with RLS than in subjects without sleep disorders.
Material and methods
We performed a retrospective analysis of polysomnographic
(PSG) recordings and clinical data of 30 consecutive patients
with RLS, diagnosed at the Vitalmed Sleep Clinic in Helsinki,
Finland. All patients were diagnosed according to the
International Restless Leg Syndrome Study Group
(IRLSSG) diagnostic criteria [2]. The diagnosis was made
by a clinician admitting the patient to the sleep clinic. The
signs, symptoms, and diagnosis were noted in the patient’s
file. We analyzed the first PSG recordings of the patients,
taken before initiation of any form of therapy for RLS. The
clinical data were taken from the patients’ files. Those patients
that were taking drugs for any other conditions maintained
their standard treatment regimens, and it was determined that
no therapeutic changes were made during 2 weeks before the
PSG. We excluded patients with any comorbid sleep-related
breathing disorders (SRBD), such as sleep apnea, since
SRBDs have significant influences on BP.
Twenty-seven subjects with no clinical sleep disorder were
included as the control group. These subjects were consecu-
tive patients that underwent a somnological diagnostic battery
due to subjective complaints of daytime fatigue or sleepiness,
and the results of the diagnostic procedures (history, clinical
examination, PSG) revealed that no control subjects had any
significant sleep disorder. The subjects underwent a PSG re-
cording and were included only if they were not prescribed
any drugs potentially influencing sleep architecture. The clin-
ical data of the patients were taken from their medical files.
The examined and control groups were selected to detect a
10 % difference in values of blood pressure with power test
0.75 (sample size, RLS = 30; sampling ratio = 1.1 (RLS/
controls)).
Patients underwent a single PSG study. All recordings were
performed with the SOMNOscreen plus PSG system
(Somnomedics, Randersacker, Germany). Sleep recordings
included four EEG leads, two bilateral electro-oculogram
leads (EOG), bilateral chin electromyographic leads (EMG),
two surface EMG leads placed on the left and right anterior
tibialis muscles (recording periodic limb movements (PLMs)
in sleep and wake). Respiration was recorded with a nasal
cannula, thoracic and abdominal strains, and finger oxymetry.
Electrocardiograms were recorded with a single precardial
lead. The PSG included beat-to-beat blood pressure measure-
ment determined via measurement of pulse transit time (PTT)
[16]. The measurement of blood pressure was continuous and
non-invasive and did not disturb the sleep of the patients. The
PTT-based measurement of BP was calibrated and then vali-
dated against sphygmomanometric (cuff) measurement of BP
on the brachial artery, at the beginning of recording.
The PSG recordings were scored according to the
American Academy of Sleep Medicine guidelines [17]. The
following sleep parameters were calculated: total sleep time
(TST); sleep efficiency (SE); latency of stages 1, 2, slow-wave
sleep (SWS), and REM sleep; duration of stages 1, 2, SWS,
and REM; Sleep Stage Change Index (number of transitions
between the sleep stages per hour of sleep); the Wake Index
(WI; number of awakenings per hour of sleep), duration of
Wake after Sleep Onset (WASO), and PLMS index (PLMSI).
For the assessment of the cardiovascular system, the fol-
lowing values were calculated: mean systolic and diastolic
blood pressure (SBP and DBP, respectively), and heart rate
(HR) during the “day” (“day”was defined as the time from the
start of recording until the “lights-off” moment, and from the
“lights-on” moment until the end of recording), during the
night (defined as the time between “lights-off” and “lights-
on” moments), and during wake and sleep periods.
Values of nocturnal and diurnal blood pressure were com-
pared between patients with RLS and controls. Values of day-
time and sleep BP were compared for each group to check
whether a nocturnal dipping of BP appears. Patients with RLS
were further divided into 2 subgroups: subjects with a signif-
icant (>15) PLMSI and subjects without significant PLMSI
The cut-off value of PLMSI >15 was chosen accordingly to
available literature [18]. Values of BPwere compared between
those two subgroups. For further analysis of the impact of
PLMSI on BP, coefficients of correlation between PLMSI
and values of BP were calculated.
The study was approved by the Independent Bioethical
Committee for Scientific Research at the Medical University
of Gdansk.
Results
Participants included 30 RLS patients and 27 controls. Their
demographic and clinical data are presented in Table 1. The
groups did not differ in terms of age or sex.
Patients with RLS had shorter total sleep time, lower sleep
efficiency, longer sleep latency, longer time of wake after
sleep onset, and a higher index of periodic limb movements
(PLMS-I). Nineteen patients with RLS (63.3 %) had PLMSI
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higher than 15. The exact data on sleep parameters are pre-
sented in Table 2.
Mean values of blood pressure measured during daytime
and wake did not differ between the groups. There was a
statistically significant difference in mean values of systolic
blood pressure measured during nighttime and during sleep
(Table 3).
In the control group, values of systolic BP during the night
and sleep were significantly lower than the values of systolic
BP during the day. However, no such difference was observed
in the RLS group, nor was it observed for the values of dia-
stolic BP in either group (Table 4).
There was no significant difference in values of nocturnal
BP between patients with RLS with increased PLMSI (>15)
and without increased PLMSI (Table 5). The mean values of
BP for patients with RLS and increased PLMSI, with RLS and
without increased PLMSI, and controls were shown in Fig. 1.
There was no significant correlation between PLMSI and noc-
turnal systolic BP (r = 0.24; p = 0.07) and nocturnal diastolic
BP (r = 0.24; p = 0.07) in the examined population (Table 6).
Logistic regression models were built to clarify the relation
between sleep parameters and systolic BP during night and
sleep. The only significant factor influencing the values of
systolic blood pressure in night and in sleep was PLMSI (re-
spectively: OR 1.040; 95 % CI 1.003–1.079; p = 0.0322 and
OR 1.041; 95 % CI 1.004–1.0979; p = 0.0298).
Discussion
In this study, we compared patients with RLS to subjects
without a sleep disorder. We found that patients with RLS
had higher nocturnal systolic blood pressures and that there
was no significant difference (no dip) between values of day-
time (evening) and nighttime values of systolic blood
pressure.
We have compared very similar groups of subjects, differ-
ing clinically in terms of the presence of RLS. Prevalence of
symptoms of metabolic syndrome and cardiovascular morbid-
ity was not significantly higher among patients with RLS,
which remains in concordance with results of epidemiologic
studies [4, 19, 20].
Our findings are in concordance with the results of studies
showing a higher prevalence of cardiovascular risk factors,
like hypertension or hypercholesterolemia in patients with
RLS. Such a conclusion was drawn from both large
population-based studies [4, 19–24] and small observational
studies [9].
The patients with RLS in our study had significantly higher
values of nocturnal systolic blood pressure compared to the
controls. A number of published articles have described the
connection between RLS and/or PLMS, and increases in both
heart rate and blood pressure. For example, Manconi et al.
found a significant increase in heart rate following PLMS
[25]. Pennestri et al. found that in patients with RLS, PLMS
are followed by a significant increase in blood pressure and
that the increase is even greater after PLMS associated with a
microarousal [13]. A similar observation was made by
Siddiqui et al., who found a significantly higher increase in
BP following PLMS, even when compared to the BP increase
following a voluntary leg movement [14]. Recently, those
observations were confirmed in healthy subjects [15]. These
findings suggest that patients with PLMS experience frequent
transient elevations of blood pressure through the night, lead-
ing to a persistently increased nocturnal blood pressure. This
is consistent with our results, in which the subjects with RLS
had significantly more PLMS and PLMS with arousals.
Table 1 Demographic and clinical characteristics of study subjects
with restless legs syndrome (RLS) and controls
RLS (n = 30) Controls (n = 27) p
Sex (M/F) 12/18 12/15 NS
Age (mean ± SD, years) 49.0 ± 14.9 44.3 ± 16.3 NS
BMI (mean ± SD, kg/m2) 26.4 ± 4.8 25.3 ± 4.6 NS
Hypertension (n (%)) 5 (16.7 %) 2 (7.4 %) NS
Coronary heart disease (n (%)) 1 (3.3 %) 0 NS
Stroke (n (%)) 2 (6.7 %) 0 NS
Diabetes (n (%)) 3 (10.1 %) 0 NS
Hypercholesterolemia (n (%)) 5 (16.7 %) 0 NS
Table 2 Sleep parameters of patients with restless legs syndrome
(RLS) and controls
RLS Controls p
TST (mean ± SD; min) 370.7 ± 87.9 418.8 ± 57.9 0.01
Sleep efficiency (%) 74.5 ± 14.4 84.3 ± 8.8 0.002
Sleep latency (mean ± SD; min) 26.0 ± 25.7 16.5 ± 9.6 0.04
Wake Index 5.4 ± 2.3 4.9 ± 2.9 NS
WASO (mean ± SD, min) 89.0 ± 65.9 54.3 ± 43.0 0.01
AHI (mean ± SD) 1.3 ± 1.4 1.5 ± 1.3 NS
PLMS-I (mean ± SD) 26.9 ± 25.5 12.0 ± 13.4 0.004
PLMSA-I (mean ± SD) 4.5 ± 5.5 2.1 ± 3.7 0.03
Arousal Index (mean ± SD) 17.3 ± 9.5 14.2 ± 5.0 NS
S1 (mean ± SD, % TST) 17.6 ± 6.8 16.0 ± 8.5 NS
S2 (mean ± SD, % TST) 46.2 ± 8.1 49.3 ± 8.5 NS
SWS (mean ± SD, % TST) 17.2 ± 7.4 16.4 ± 8.9 NS
REM (mean ± SD, % TST) 17.9 ± 6.8 18.2 ± 6.1 NS
Nocturnal SVB 19.8 ± 7.8 19.8 ± 6.4 NS
HR (mean ± SD) 59.6 ± 8.4 62.0 ± 9.9 NS
TST total sleep time, WASO time of wake after sleep onset, AHI apnea/
hypopnea index, PLMS-I periodic limb movements in sleep index,
PLMSA-I periodic limb movements in sleep with arousal index, SVB
sympathovagal balance, HR heart rate, SD standard deviation
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The higher values of nocturnal systolic BP found in pa-
tients with RLS may be related to their disturbed sleep archi-
tecture. Indeed, patients with RLS had longer sleep latency
and longer time of wake after sleep onset (WASO) what
may result in higher values of BP in night. It must be noted
then that systolic BP measured separately for the period of
sleep was also higher in the group of patients with RLS.
Surprisingly, significant differences between the
groups were found only for values of systolic blood
pressure. Values of diastolic blood pressure were higher
in the RLS group but that difference did not reach sta-
tistical significance. Data published so far showed that
RLS and/or PLMS influence both systolic and diastolic
BP, nevertheless some exceptions. Siddiqui et al. found
that PLMS without arousal did not lead to a significant
increase of diastolic BP [14]. Oh et al. compared pa-
tients with Parkinson’s disease and with/without RLS
and described significantly higher values only of systol-
ic BP in subjects with Parkinson’s disease and RLS
[26]. Those data suggest that RLS and PLMS may be
related to a sympathetic arousal system, but this relation
may be too weak to influence diastolic blood pressure.
We also noted that unlike the control group, in which
systolic blood pressure dipped at night, there was no
significant change from diurnal to nocturnal systolic
blood pressure in the group of patients with RLS.
Notably, recently published data showed that RLS is
an independent determinant for a non-dipping blood
pressure pattern [9]. Furthermore, non-dipping blood
pressure patterns were found to be related to higher
RLS severity scores [27]. However, we had very limited
data on the daytime BP values—it was measured from
the beginning of the recording until the “lights-off” mo-
ment, so it reflects only evening BP values. Thus, this
observation does not imply that patients with RLS have
non-dipping BP patterns, though it does suggest that
further study of this phenomenon is warranted. It is of
note that in terms of non-dipping, the situation in RLS
could be similar to that in obstructive sleep apnea syn-
drome (OSAS). There is a marked vasoconstriction and
increase in BP following each episode of airway ob-
struction in OSAS [28], and those numerous surges of
BP appearing throughout the night inhibit the nocturnal
dip of BP. A role analogic to airway obstruction in
OSAS could be played by PLMS in RLS. The final
result is the same—repetitive increases in BP leading
to a non-dipping pattern of BP. Non-dipping is consid-
ered an important risk factor of cardiovascular morbidity
and organ damage due to hypertension [29] and there-
fore requires normalization. Normalization of BP is
achieved with continuous positive airway pressure
(CPAP) therapy in case of OSAS [30]. It can be spec-
ulated that in case of RLS, a similar effect could be
achieved with suppressing PLMS, e.g., with dopaminer-
gic treatment.
Another issue requiring further studies is the time course of
changes of BP during the nights in patients with RLS. In our
study, we have focused on overall nocturnal blood pressure
while it would be of interest to observe whether values of BP
differ between parts of nights dominated by slow-wave sleep
Table 3 Mean values of blood
pressure (BP) in patients with
restless legs syndrome (RLS) and
controls
RLS Controls p
Systolic BP in wake (mean ± SD, mmHg) 123.0 ± 12.7 121.6 ± 22.5 NS
Systolic BP in day (mean ± SD, mmHg) 128.1 ± 14.3 123.7 ± 14.8 NS
Diastolic BP in wake (mean ± SD, mmHg) 77.9 ± 12.2 74.7 ± 9.4 NS
Diastolic BP in day (mean ± SD, mmHg) 79.0 ± 12.4 75.6 ± 9.7 NS
Systolic BP in sleep (mean ± SD, mmHg) 123.5 ± 14.1 116.1 ± 15.8 0.03
Systolic BP in night (mean ± SD, mmHg) 124.4 ± 14.7 116.5 ± 15.6 0.03
Diastolic BP in sleep (mean ± SD, mmHg) 76.6 ± 10.8 72.2 ± 11.7 NS
Diastolic BP in night (mean ± SD, mmHg) 77.0 ± 10.8 72.5 ± 11.7 NS
Table 4 Differences between values of blood pressure (BP) measured during the day and the night in subjects with restless legs syndrome (RLS) and
controls
Daytime values Nighttime values p1 Sleep values p2
Systolic BP—control group (mean ± SD, mmHg) 123.7 ± 14.8 116.5 ± 15.6 0.04 116.1 ± 15.8 0.04
Systolic BP—RLS group (mean ± SD, mmHg) 128.1 ± 14.3 124.4 ± 14.7 NS 123.5 ± 14.1 NS
Diastolic BP—control group (mean ± SD, mmHg) 75.6 ± 9.7 72.5 ± 11.7 NS 72.2 ± 11.7 NS
Diastolic BP—RLS group (mean ± SD, mmHg) 79.0 ± 12.4 77.0 ± 10.8 NS 76.6 ± 10.8 NS
p1 : p values for comparison daytime values vs. nighttime values (t test); p2 : p values for
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and REM sleep. Such an analysis should become a part of
upcoming projects.
The main limitation of our study, besides the relatively
small group size, was that the patients were not drug-naïve
in terms of antihypertensive drugs. Nevertheless, it was deter-
mined that the drug regimen was stable in the patients. The
relatively low BP in both groups suggests that hypertension
was well controlled in the patients, and the lack of difference
in the daytime BP between the groups (despite the higher
prevalence of hypertension in the RLS group) allows us to
draw conclusions from the comparison of nocturnal blood
pressure.
Participants of our study underwent only a single
night in a sleep laboratory, and some changes in their
sleep architecture could result from the first night effect.
We wanted our results to be comparable with results
from other groups, and published papers focusing on
relation between RLS, PLMS, and BP were based upon
single night observations [13–15, 31].
Another factor that could have influenced our results
was presence of respiratory effort related arousals
(RERAs). Patients with sleep-related breathing disorders
were excluded from the study, and therefore, RERAs
were not included in the analysis. It was believed that
in groups selected in this way, respiratory events would
not have much impact on values of blood pressure.
Nevertheless, in must be remembered that RERAs,
when present, have a significant impact on functions
of cardiovascular system [32, 33]. The same must be
noted on values of oxygen saturation: as patients with
sleep-disordered breathing were not participating in this
study, values of oxygen saturation were not included
in to ana lys i s . The fu tu re p ro j ec t s a iming a t
disentangling the role of elements of sleep architecture
in changes of BP should take RERA and values of
oxygen saturation into account as relation between the
latter factor and values of BP is well proven [34].
Our study showed that patients with RLS are at a higher
risk of developing increased blood pressure during the night.
This result does not establish a causal relation between RLS
and hypertension, but some practical conclusions may be
drawn from this study. First, blood pressure in patients with
RLS should be monitored with 24-h ambulatory blood pres-
sure monitoring (ABPM), as they may have normal values of
blood pressure during the day but increased blood pres-
sure at night. Second, a higher evening dose of the
patient’s preferred antihypertensive drug should be con-
sidered in patients with RLS and hypertension, in an
effort to prevent the increased nocturnal blood pressure.
Future studies should concentrate on (1) clarifying the
direction of the relationship between RLS and hyperten-
sion, (2) clarifying the relationship between RLS and
Table 5 Mean values of nocturnal blood pressure in patients with RLS with PLMSI >15 and PLMS <15
RLS (+) PLMSI <15 (n = 11) RLS(+) PLMSI >15 (n = 19) p
Systolic BP in sleep (mean ± SD, mmHg) 122.6 ± 14.2 124.0 ± 14.4 NS
Systolic BP in night (mean ± SD, mmHg) 123.0 ± 14.1 125.2 ± 15.4 NS
Diastolic BP in sleep (mean ± SD, mmHg) 73.1 ± 10.0 78.6 ± 11.0 NS
Diastolic BP in night (mean ± SD, mmHg) 73.5 ± 10.1 79.0 ± 10.1 NS
Fig. 1 Values of nocturnal BP in
patients with RLS and in controls.
BP blood pressure, SBP systolic
blood pressure, DBP diastolic
blood pressure, RLS PLMS(+)
patients with RLS with PLMSI
>15, RLS PLMS(−) patients with
RLS with PLMSI < 15, SBP sleep
systolic blood pressure in sleep,
SBP night systolic blood pressure
in night, DBP sleep diastolic
blood pressure in sleep, DBP
night diastolic blood pressure in
night
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metabolic disorders such as hypercholesterolemia, and
(3) assessing the influence of RLS therapy on the dys-
regulated blood pressure.
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